Syensqo NV

Capital Structure and Liquidity Syensqo's liquidity position is characterized by a current ratio of 2.04, indicating a moderate ability to meet short-term obligations. The company holds EUR 861 million in cash and equivalents, but its long-term debt of EUR 2.96 billion suggests a leveraged capital structure. The debt-to-equity ratio of 0.49 reflects a relatively balanced capital structure, but the negative free cash flow of EUR -143 million indicates pressure on liquidity generation. ### Profitability and Returns Syensqo's profitability is underperforming, with a net loss of EUR -62 million and a negative return on equity of -1.02%. The company's operating income of EUR 195 million is below the industry median for Diversified Chemicals, and its return on assets of -0.54% is also subpar. These metrics suggest that the company is struggling to convert its asset base into profitable returns. ### Segments and Geographic Exposure Syensqo operates in a diversified chemical portfolio, but the financial data does not provide a breakdown of revenue by segment or geography. As a result, it is not possible to assess the company's exposure to specific markets or product lines. However, the lack of segment detail may indicate a concentration risk if the company is overly reliant on a few key markets or products. ### Growth Trajectory The company's recent financial performance shows a decline in profitability, with a net loss in the latest reporting period. Analysts have provided a mixed outlook, with a mean price target of EUR 61.47 and a median of EUR 60.00. The mean recommendation of 2.40 suggests a cautious stance, with 3 strong-buy ratings and 8 buy ratings. The absence of clear revenue growth in the data implies that the company may need to address operational inefficiencies or market challenges to restore growth. ### Risk Factors The risk assessment highlights a medium liquidity risk, primarily due to the company's negative free cash flow and the fact that net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential in the basic shares outstanding. However, the company's capital expenditure of EUR -536 million and the negative net income raise concerns about its ability to sustain operations without external financing. ### Recent Events Recent filings and transcripts do not provide specific details on Syensqo's strategic initiatives or operational changes. However, the company's financial performance and analyst ratings suggest that investors are closely monitoring its ability to improve profitability and manage debt levels.